Business Daily | by Brian Ngugi
One of Bangladesh’s largest drugmakers, Square Pharmaceuticals, will start producing medicines at its multibillion production facility in Kenya in the next four months, targeting unmet demand in Kenya, Tanzania, Rwanda, Burundi, Uganda and South Sudan.
The pharmaceutical firm started the construction of a plant in 2018 at the tax-friendly export processing zones (EPZ) in Athi River with an initial investment of Sh2.58 billion ($25 million) and now says it is ready to begin commercial production…
